Product Name |
Recombinant Human Apolipoprotein A-IV (APOA4) Protein |
Product Overview |
This recombinant human Apolipoprotein A-IV (APOA4) protein includes amino acids 21-396aa of the target gene is expressed in HEK293 Cells.The protein is supplied in lyophilized form and formulated in phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5% trehaloseprior to lyophilization. |
Target Uniprot Id |
P06727 |
Recommended Name |
Apolipoprotein A-IV |
Gene Name |
APOA4 |
Synonyms |
Apolipoprotein A-IV; Apo-AIV; ApoA-IV; Apolipoprotein A4; APOA4 |
Species |
Human |
Predicted Molecular Mass |
44.4 kDa |
Expression System |
Mammalian Cell |
Expression Range |
21-396aa |
Tag |
C-6His |
Purity |
>85% |
Formulation |
Lyophilized |
Buffer |
Phosphate buffered saline (pH7.4) containing 0.01% sarcosyl, 5%Trehalose |
Storage Condition |
1. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. 2. Avoid repeated freeze-thaw cycles. 3. Store working aliquots at 4°C for up to one week. 4. In general, protein in liquid form is stable for up to 6 months at -20°C/-80°C. Protein in lyophilized powder form is stable for up to 12 months at -20°C/-80°C. |
Reconstitution Instruction |
Briefly centrifuged the vial prior to opening to bring the contents to the bottom. Reconstitute protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. It is recommended to add 5-50% of glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. The default final concentration of glycerol is 50%. |
Applications |
Positive Control; Immunogen; SDS-PAGE; WB |
Research Area |
Cardiovascular, Cancer |
Target Function |
May have a role in chylomicrons and VLDL secretion and catabolism. Required for efficient activation of lipoprotein lipase by ApoC-II; potent activator of LCAT. Apoa-IV is a major component of HDL and chylomicrons. |
Subcellular Location |
Secreted. |
Protein Family |
Apolipoprotein A1/A4/E family |
Tissue Specificity |
Synthesized primarily in the intestine and secreted in plasma. |